EU Osteoporosis Drugs market Analysis


  • Type: Common Disease Area
  • Published : February 2022
  • Region: Europe
  • Country: Other
  • Report ID : 5050

  • Format: PPT, PDF

EU Osteoporosis Drugs market Analysis: Segmented by Drug type, Route of Administration and Country – Growth, Market Size, Future Prospects & Competitive Analysis, 2020–2026

SKU: 5050 Categories: ,

Report Description of the EU Osteoporosis Market

Research Scope and Assumption

  • The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
  • The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
  • We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
  • All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
  • Inflation has not been accounted for in order to estimate and forecast the market
  • Numbers may not add up due to rounding off

Reason to buy the report:

  • Facilitate decision-making based on strong current and forecast data for EU Osteoporosis  Treatment Market
  • Develop strategies based on the latest regulatory framework
  • Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
  • Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the EU Osteoporosis Drug market
  • Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • We have technically sound team which do a deep dive research and also provide strategy-based consulting analysis

EU Osteoporosis Drugs market Executive Summary

Osteoporosis is a condition oriented with high-risk fractures in men, postmenopausal women, geriatric population. and others. Osteoporosis patients mainly tend to break bones, hip, forearms, spine, and wrist. Therefore, it is described as the metabolic disease that reduces bone mineral density leading to fracture. Thus, the increase in the prevalence of osteoporosis is boosting the osteoporosis drugs market growth. Osteoporosis is mainly observed in women. According to the International Osteoporosis Foundation, it is observed that 25% of women and 5% of men aged above 65 are considered as the majority of people suffering from osteoporosis

Market Size and Key Findings

The EU Osteoporosis Drugs market size stood at around USD XX billion in 2020 and is projected to reach USD xx billion by 2026, exhibiting a CAGR of 4% during the forecast period.

EU Osteoporosis Drugs market is likely to grow at remarkable rate during the forecast period. Some of factors that prompt to increase risk of osteoporosis are rheumatoid arthritis, family history of osteoporosis, long term usage of medications that affect bone strength or hormone level such as ora steroid is propagating the growth. Moreover, a rise in healthcare expenditure in discovery and drug development coupled with an increase in awareness of drugs available for the treatment of osteoporosis are the significant factors influencing the osteoporosis treatment market growth during the forecast period.

Market Dynamics

Market Growth Drivers Analysis

Osteoporosis drugs are mainly used in the treatment of the patients suffering from osteoporosis, multiple fractures, geriatric people suffering from osteoarthritis, and women suffering from postmenopausal disorders. A rise in awareness about disease and available treatment options has influenced the adoption of osteoporosis treatment across the globe. Therefore, the adoption of the osteoporosis treatment has triggered the manufacturers in the development of the new product. Evenity is indicated for the bone-forming monoclonal antibody which works by inhibiting the sclerostin activity by Increasing bone formation and reducing the bone resorption. Such introductions of advanced drug with more effectiveness are significantly driving the growth of the global osteoporosis drugs market during the forecast period.

Market Restraints

Growth in the market for osteoporosis drugs is likely to be delayed due to side effects and risks involved with osteoporosis medications. For eg, heartburn, muscle and joint pain, diarrhea, and stomach or esophagus ulcers are risks associated with the drug class of bisphosphonates. Other than this, other classes of drugs also have side effects in patients. Many risks caused by osteoporosis medications include bone trauma, bone breaks, and urinary infection. Moreover, the patent expiry of new branded products and the restricted reimbursement by healthcare payers often adversely affect the growth of the market

Competitive Landscape

Key Players

Some of the key players include Amgen, Inc., F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC (GSK), Merck & Co., Inc., Novartis AG, Pfizer, Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceuticals Industries Ltd., Allergan PLC, and Eli Lilly and Company.

Products in Pipeline

Purdue University innovators developed a stabilized form of human calcitonin, which is a peptide drug already used for people with osteoporosis. Researchers at Purdue created a prodrug form of the peptide hormone to increase its effectiveness as an osteoporosis treatment. In humans, calcitonin is the hormone responsible for normal calcium homeostasis. When prescribed to osteoporosis patients, calcitonin inhibits bone resorption, resulting in increased bone mass

Notable Recent Deals

The biosimilar teriparatide biosimilar named terrosa by GEDEON Richter was launched in Europe after the patent expiry for its reference product. This product is indicated for the treatment of osteoporosis in postmenopausal women and in men with a high risk of fracture along with osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk of fracture.                  

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario

National guidelines of Europe for the assessment and treatment of osteoporosis are available from the majority of member states. Their scope variously covers post-menopausal women, men, glucocorticoid-induced osteoporosis and population-based screening.

1. Report Description of the EU Osteoporosis Drugs market
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. EU Osteoporosis Drugs market Executive Summary
2.1 EU Osteoporosis Drugs market- Industry Snapshot & key buying criteria, 2020-2026
2.2 Market Size, Growth Prospects and Key findings
3. Market Dynamics of EU Osteoporosis Drugs market
3.1 Market Growth Drivers Analysis
3.1.1 Increase in the prevalence of osteoporosis
3.1.2 Growth of the market for osteoporosis drugs
3.1.3 Rise in sedentary lifestyles worldwide
3.2 Market Restraints Analysis
3.2.1 Side effects and risks involved with osteoporosis medications
3.2.2 Patent expiry of new branded products
3.2.3 Restricted reimbursement by healthcare payers
4. EU Osteoporosis Treatment Market Segmentation
4.1 By Drug Type Analysis:
4.1.1 Rank Ligand Inhibitors
4.1.2 Parathyroid Hormone Therapy
4.1.3 Calcitonin
4.1.4 Selective Estrogen Inhibitors Modulator (SERM)
4.1.5 Other Drug Classes
4.2 By Route of Administration Analysis:
4.2.1 Oral
4.2.2 Injectable
4.2.3 Other Route of Administration
4.3 By Country:
4.3.1 Germany
4.3.2 UK
4.3.3 France
4.3.4 Russia
4.3.5 Italy
4.3.6 Spain
4.3.7 Rest of Europe
5. EU Osteoporosis Major Products Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
6.2 Products in Pipeline
6.3 R&D Initiatives in EU Osteoporosis Drugs Market
6.4 Notable recent deals in EU Osteoporosis Drug Market
6.4.1 Joint Ventures
6.4.2 Partnerships
6.4.3 Mergers & Acquisitions
6.4.4 Strategic divestments
7. Key Company Profiles
7.1 Amgen, Inc. Company overview
Product & Services, Strategies & Financials
7.2 F. Hoffmann-La Roche Ltd.
Product & Services, Strategies & Financials
7.3 GlaxoSmithKline PLC (GSK) Company overview
Product & Services, Strategies & Financials
7.4 Merck & Co., Inc. Company overview
Product & Services, Strategies & Financials
7.5 Novartis AG Company overview
Product & Services, Strategies & Financials
7.6 Pfizer, Inc.Company overview
Product & Services, Strategies & Financials
7.7 Sun Pharmaceutical Industries Ltd.
Product & Services, Strategies & Financials
7.8 Teva Pharmaceuticals Industries Ltd.
Product & Services, Strategies & Financials
7.9 Allergan PLC
Product & Services, Strategies & Financials
7.10 Eli Lilly and Company.
Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
8.1 Policy changes and Reimbursement scenario
8.2 Government Initiatives / Intervention programs
9. Factors Driving Future Growth
9.1 New Trends and Development of EU Osteoporosis Drugs market
9.2 Future Opportunities
10. Strategic Recommendations

EU Osteoporosis Treatment Market Segmentation

By Drug Type:

Based on the drug type, the market is segmented into Rank Ligand Inhibitors, Parathyroid Hormone Therapy, Calcitonin, Selective Estrogen Inhibitors Modulator (SERM) and Other Drug Classes which are highly recommended for Osteoporosis, thereby upscaling the market.

  • Rank Ligand Inhibitors
  • Oarathyroid Hormone Theraoy
  • Calcitonin
  • Selective Estrogen Inhibitors Modulator (SERM)
  • Other Drug Class

By Route Of Administration:

In terms of route of administration, the market is segmented into oral,Injactable  and other route of administration

  • Oral
  • Injectable
  • Other Route of Administration

By Country:

Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe

  • Germany
  • UK
  • France
  • Spain
  • Russia
  • Italy
  • Rest of Europe

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements